Karin Seifert

Current scenario of drug development for leishmaniasis.

Simon L. Croft, Karin Seifert, Vanessa Yardley · PubMed · 2006 · 392 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Science +14

Scan speed limit in atomic force microscopy

Hans‐Jürgen Butt, Peter Siedle, Karin Seifert et al. · Journal of Microscopy · 1993 · 227 citations

Engineering, Microscopy, Mechanical Engineering +16

In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs

Karin Seifert, Simon L. Croft · Antimicrobial Agents and Chemotherapy · 2005 · 203 citations · Full text

Pharmaceutical Science, Antiparasitic Agent, Antibiotic Adjuvant +18

Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)

Karin Seifert, Sangeeta Matu, F. Javier Pérez‐Victoria et al. · International Journal of Antimicrobial Agents · 2003 · 179 citations

Leishmania Donovani, Bioorganic Chemistry, Parasitic Protozoa +7

Nursery pollination by a moth in <i>Silene latifolia</i>: the role of odours in eliciting antennal and behavioural responses

Stefan Dötterl, Andreas Jürgens, Karin Seifert et al. · New Phytologist · 2005 · 173 citations